Subcutaneous immunization with the fusion protein ΔA146Ply-SP0148 confers protection against Streptococcus pneumoniae infection

Microbial Pathogenesis - Tập 162 - Trang 105325 - 2022
Yao Wang1, Lingyin Xia1, Guangli Wang1, Huifang Lu1, Hui Wang1, Shilu Luo1, Tao Zhang1, Song Gao1, Jian Huang1, Xun Min1
1Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China

Tài liệu tham khảo

Bogaert, 2004, Streptococcus pneumoniae colonisation: the key to pneumococcal disease[J], Lancet Infect. Dis., 4, 144, 10.1016/S1473-3099(04)00938-7

O'brien, 2009, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates[J], Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6

Qiu, 2017, Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice[J], J. Microbiol., 55, 823, 10.1007/s12275-017-7262-1

Cherazard, 2017, Antimicrobial resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications[J], Am. J. Therapeut., 24, e361, 10.1097/MJT.0000000000000551

Ahmed, 2019, Antibiotic resistance in Bangladesh: a systematic review[J], Int. J. Infect. Dis., 80, 54, 10.1016/j.ijid.2018.12.017

Pichichero, 2016, Next generation protein based Streptococcus pneumoniae vaccines[J], Hum. Vaccines Immunother., 12, 194, 10.1080/21645515.2015.1052198

Briles, 2019, Pneumococcal vaccines[J], Microbiol. Spectr., 7, 10.1128/microbiolspec.GPP3-0028-2018

Marra, 2019, Efficacy and safety of the pneumococcal conjugate-13 valent vaccine in adults[J], Aging Dis., 10, 404, 10.14336/AD.2018.0512

Tai, 2016, Streptococcus pneumoniae serotype distribution and pneumococcal conjugate vaccine serotype coverage among pediatric patients in east and southeast asia, 2000-2014: a Pooled Data Analysis[J], Vaccines (Basel), 4

Jacques, 2020, Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin[J], Nat. Commun., 11, 1892, 10.1038/s41467-020-15751-6

Suaya, 2020, Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017[J], J. Infect., 81, 557, 10.1016/j.jinf.2020.07.035

Galanis, 2016, Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden[J], Eur. Respir. J., 47, 1208, 10.1183/13993003.01451-2015

Darrieux, 2015, Current status and perspectives on protein-based pneumococcal vaccines[J], Crit. Rev. Microbiol., 41, 190, 10.3109/1040841X.2013.813902

Converso, 2020, The long search for a serotype independent pneumococcal vaccine[J], Expert Rev. Vaccines, 19, 57, 10.1080/14760584.2020.1711055

Cornick, 2017, The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1[J], Vaccine, 35, 972, 10.1016/j.vaccine.2016.12.037

Moffitt, 2011, T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization[J], Cell Host Microbe, 9, 158, 10.1016/j.chom.2011.01.007

Moffitt, 2014, Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins[J], Infect. Immun., 82, 2079, 10.1128/IAI.01632-13

Huang, 2019, Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein[J], Microb. Pathog., 129, 206, 10.1016/j.micpath.2019.02.018

Moffitt, 2016, Rationale and prospects for novel pneumococcal vaccines[J], Hum. Vaccines Immunother., 12, 383, 10.1080/21645515.2015.1087625

Geno, 2015, Pneumococcal capsules and their types: past, present, and future[J], Clin. Microbiol. Rev., 28, 871, 10.1128/CMR.00024-15

Anderson, 2017, Pneumolysin as a potential therapeutic target in severe pneumococcal disease[J], J. Infect., 74, 527, 10.1016/j.jinf.2017.03.005

Hu, 2013, Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccine[J], J. Pharmaceut. Sci., 102, 387, 10.1002/jps.23375

Salha, 2012, Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury[J], Infect. Immun., 80, 2212, 10.1128/IAI.06348-11

Wu, 2010, Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice[J], Infect. Immun., 78, 1276, 10.1128/IAI.00473-09

Kirkham, 2006, Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines[J], Infect. Immun., 74, 586, 10.1128/IAI.74.1.586-593.2006

Liu, 2014, Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A[J], Infect. Immun., 82, 1666, 10.1128/IAI.01391-13

Su, 2017, Subcutaneous immunization with fusion protein DnaJ-ΔA146Ply without additional adjuvants induces both humoral and cellular immunity against pneumococcal infection partially depending on TLR4[J], Front. Immunol., 8, 686, 10.3389/fimmu.2017.00686

Cuadros, 2004, Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses[J], Infect. Immun., 72, 2810, 10.1128/IAI.72.5.2810-2816.2004

Converso, 2017, A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice[J], Vaccine, 35, 5140, 10.1016/j.vaccine.2017.08.010

Goulart, 2013, Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives[J], PLoS One, 8, 10.1371/journal.pone.0059605

Darrieux, 2007, Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition[J], Infect. Immun., 75, 5930, 10.1128/IAI.00940-07

Wang, 2018, Expression of toll-like receptor 2 by dendritic cells is essential for the DnaJ-ΔA146Ply-mediated Th1 immune response against Streptococcus pneumoniae[J], Infect. Immun., 86, 10.1128/IAI.00651-17

Li, 2018, Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice[J], Microb. Pathog., 123, 115, 10.1016/j.micpath.2018.06.041

Cohen, 2011, Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation[J], PLoS One, 6, 10.1371/journal.pone.0025558

André, 2020, Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae[J], Vaccine, 38, 4146, 10.1016/j.vaccine.2020.04.050

Lu, 2014, Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines[J], Immunol. Invest., 43, 717, 10.3109/08820139.2014.930478

Ramos-Sevillano, 2019, Mechanisms of naturally acquired immunity to Streptococcus pneumoniae[J], Front. Immunol., 10, 358, 10.3389/fimmu.2019.00358

Wilson, 2017, Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens[J], PLoS Pathog., 13, 10.1371/journal.ppat.1006137

Richard, 2014, TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse Influenza A co-infection model[J], PLoS Pathog., 10, 10.1371/journal.ppat.1004339

Lu, 2009, Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide[J], Infect. Immun., 77, 2076, 10.1128/IAI.01554-08

Blander, 2006, Toll-dependent selection of microbial antigens for presentation by dendritic cells[J], Nature, 440, 808, 10.1038/nature04596

Nimmerjahn, 2005, Divergent immunoglobulin g subclass activity through selective Fc receptor binding[J], Science, 310, 1510, 10.1126/science.1118948

Martin, 1998, The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice[J], J. Immunol. Methods, 212, 187, 10.1016/S0022-1759(98)00015-5

Hjertner, 2018, A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine[J], Vaccine, 36, 3340, 10.1016/j.vaccine.2018.04.054

Van Rossum, 2005, Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model[J], Infect. Immun., 73, 7718, 10.1128/IAI.73.11.7718-7726.2005

Wilson, 2015, Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses[J], Mucosal Immunol., 8, 627, 10.1038/mi.2014.95

Elhaik Goldman, 2016, Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice[J], Int. J. Mol. Med., 37, 1127, 10.3892/ijmm.2016.2512

Fukuyama, 2010, Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae[J], J. Immunol., 185, 1755, 10.4049/jimmunol.1000831

Kim, 2017, Pneumonia and Streptococcus pneumoniae vaccine[J], Arch Pharm. Res. (Seoul), 40, 885, 10.1007/s12272-017-0933-y

Hutchings, 2004, Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches[J], J. Virol., 78, 947, 10.1128/JVI.78.2.947-957.2004

Verhoeven, 2014, Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model[J], Vaccine, 32, 3205, 10.1016/j.vaccine.2014.04.004

Thông tin
Thông tin xuất bản

Microbial Pathogenesis

Tập 162

105325

Thông tin tác giả